Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dynamics of Treatment Response to Faricimab for Diabetic Macular Edema.
Fasler K, Muth DR, Cozzi M, Kvanta A, Rejdak M, Blaser F, Zweifel SA. Fasler K, et al. Among authors: cozzi m. Bioengineering (Basel). 2024 Sep 26;11(10):964. doi: 10.3390/bioengineering11100964. Bioengineering (Basel). 2024. PMID: 39451340 Free PMC article.
Sterile Intraocular Inflammation Associated With Faricimab.
Cozzi M, Ziegler A, Fasler K, Muth DR, Blaser F, Zweifel SA. Cozzi M, et al. JAMA Ophthalmol. 2024 Oct 10;142(11):1028-36. doi: 10.1001/jamaophthalmol.2024.3828. Online ahead of print. JAMA Ophthalmol. 2024. PMID: 39388167 Free PMC article.
Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR.
Freund KB, Staurenghi G, Jung JJ, Zweifel SA, Cozzi M, Hill L, Blotner S, Tsuboi M, Gune S. Freund KB, et al. Among authors: cozzi m. Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2437-2447. doi: 10.1007/s00417-022-05586-w. Epub 2022 Mar 3. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35239009 Free PMC article. Clinical Trial.
Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.
Spooner KL, Fraser-Bell S, Cozzi M, Staurenghi G, Invernizzi A, Monteduro D, Munk MR, Hong T, Chang AA. Spooner KL, et al. Among authors: cozzi m. Ophthalmology. 2020 Dec;127(12):1663-1673. doi: 10.1016/j.ophtha.2020.06.019. Epub 2020 Jun 13. Ophthalmology. 2020. PMID: 32544561 Free article. Clinical Trial.
236 results